Literature DB >> 32671658

Lower risk of primary Sjogren's syndrome in patients with dengue virus infection: a nationwide cohort study in Taiwan.

Ting-Wu Chuang1, Chyi-Huey Bai2, Chi-Ching Chang3,4, Yu-Chun Yen5, Cheng-Yi Lee6,7, Chiou-Feng Lin8,9, Chao-Ching Huang10, Ching Wen Tsai5.   

Abstract

The data concerning the association between dengue viruses (DV) infection and autoimmune diseases (ADs) remain unclear and are scarce. This nationwide population-based cohort study assessed the risk of ADs among patients with DV infection. We analyzed Taiwanese medical data from the Registry of the National Notifiable Disease Reporting System of Taiwan's Centers for Disease Control between 1998 and 2015 and identified patients with DV infection. From the entire general population data in the National Health Insurance Research Database, we randomly selected a comparison cohort that was individual matching by age, sex, residence, and index date. We analyzed the risk of ADs using a Cox proportional hazards regression model stratified by sex, age, and residence. We enrolled 29,365 patients with DV infection (50.68% men; mean age, 44.13 years) and 117,460 age-, sex-, and residence-matched controls in the present study. The incidence rates of organ-specific ADs were nonsignificantly higher in the DV cohort than in the non-DV control cohort. An approximately 70% lower risk of primary Sjogren syndrome (pSS) was evident in the DV cohort than in the non-DV control cohort with an adjusted hazard ratio of 0.30 (95% confidence interval 0.13-0.67) after adjusting for comorbidities in matched design. By contrast, the other systemic ADs were nonsignificantly lower in the DV cohort than in the non-DV control cohort. This nationwide long-term cohort study demonstrated that patients with DV infection had a lower risk of primary Sjogren syndrome than those without DV infection. Key Points • This retrospective, longitudinal cohort observational study shows that patients with DV infection had a lower risk of pSS than those without DV infection. • The DV cohort had an approximately 70% lower risk of pSS than the control group, with a multivariate-adjusted HR of 0.30. • On the basis of this result, we contended that DV infection has a protective effect that reduces the risk of pSS.

Entities:  

Keywords:  Autoimmune disease; Cohort study; Dengue virus; Risk

Mesh:

Year:  2020        PMID: 32671658      PMCID: PMC7817565          DOI: 10.1007/s10067-020-05282-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  44 in total

1.  Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes.

Authors:  Paola Zaccone; Zoltán Fehérvári; Frances M Jones; Stéphane Sidobre; Mitchell Kronenberg; David W Dunne; Anne Cooke
Journal:  Eur J Immunol       Date:  2003-05       Impact factor: 5.532

2.  CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1.

Authors:  Felix N Toka; Susmit Suvas; Barry T Rouse
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

4.  The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis.

Authors:  R Y Leavitt; A S Fauci; D A Bloch; B A Michel; G G Hunder; W P Arend; L H Calabrese; J F Fries; J T Lie; R W Lightfoot
Journal:  Arthritis Rheum       Date:  1990-08

5.  Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review.

Authors:  Shaye Kivity; Maria Teresa Arango; Michael Ehrenfeld; Omer Tehori; Yehuda Shoenfeld; Juan-Manuel Anaya; Nancy Agmon-Levin
Journal:  J Autoimmun       Date:  2014-03-15       Impact factor: 7.094

6.  Molecular mimicry of human endothelial cell antigen by autoantibodies to nonstructural protein 1 of dengue virus.

Authors:  I-Ju Liu; Chien-Yu Chiu; Yun-Ching Chen; Han-Chung Wu
Journal:  J Biol Chem       Date:  2011-01-13       Impact factor: 5.157

Review 7.  Infections and autoimmunity--good or bad?

Authors:  Urs Christen; Matthias G von Herrath
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

8.  Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Ana M Valdes; Lai-Chu See; Shue-Fen Luo; Kuang-Hui Yu; Weiya Zhang; Michael Doherty
Journal:  JAMA Intern Med       Date:  2015-09       Impact factor: 21.873

9.  Prevention of type I diabetes in nonobese diabetic mice by virus infection.

Authors:  M B Oldstone
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 10.  Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications.

Authors:  Mathilde Versini; Pierre-Yves Jeandel; Tomer Bashi; Giorgia Bizzaro; Miri Blank; Yehuda Shoenfeld
Journal:  BMC Med       Date:  2015-04-13       Impact factor: 8.775

View more
  2 in total

Review 1.  The role of virus infections in Sjögren's syndrome.

Authors:  Maria Maslinska; Kinga Kostyra-Grabczak
Journal:  Front Immunol       Date:  2022-09-06       Impact factor: 8.786

2.  Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.

Authors:  Ning Li; Lei Li; Mengyao Wu; Yusi Li; Jie Yang; Yicheng Wu; Haimin Xu; Danyang Luo; Yiming Gao; Xiaochun Fei; Liting Jiang
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.